Patents-Review.com
ClassID:

93424 ⎘

C07C311/10 - CPC Classification

Classification description:

Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings

Recent Application in this class:
#1
20260055122
2026-02-26

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

 #2
20250353813
2025-11-20

ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17

 #3
20240317676
2024-09-26

ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17

 #4
20230331685
2023-10-19

HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF

 #5
20230150989
2023-05-18

HERBICIDAL MALONAMIDES

 #6
20220356148
2022-11-10

ANTIVIRAL COMPOUNDS

 #7
20220340604
2022-10-27

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

 #8
20220024862
2022-01-27

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

 #9
20210161144
2021-06-03

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #10
20210047347
2021-02-18

Modulators of Sestrin-GATOR2 interaction and uses thereof

 #11
20200331880
2020-10-22

Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia

 #12
20200280098
2020-09-03

Free-solvent-free lithium sulfonamide salt compositions that are liquid at room temperature, and uses thereof in lithium ion battery

 #13
20200079800
2020-03-12

Modulators of Sestrin-GATOR2 interaction and uses thereof

 #14
20200024226
2020-01-23

Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

 #15
20200017488
2020-01-16

Heterocyclic inhibitors of the sodium channel

 #16
20190308935
2019-10-10

Photoinitators

 #17
20190225575
2019-07-25

Antiviral compounds

 #18
20190166847
2019-06-06

Molecules having pesticidal utility, and intermediates, compositions, and processes related thereto

 #19
20190150452
2019-05-23

MOLECULES HAVEING PESTICIDAL UTILIY AND INTERMEDIATES, COMPOSITIONS AND PROCESSES RELATED THERETO

 #20
20190048029
2019-02-14

Modulators of sestrin-GATOR2 interaction and uses thereof

 #21
20180319741
2018-11-08

Sulfonylaminobenzamide compounds as anthelmintics

 #22
20180098541
2018-04-12

Molecules having pesticidal utility and intermediates, compositions and processes related thereto

 #23
20170247265
2017-08-31

Filter medium, method for producing filter medium, water treatment module, and water treatment device

 #24
20170183333
2017-06-29

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

 #25
20170145003
2017-05-25

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

 #26
20170114080
2017-04-27

Modulators of sestrin-GATOR2 interaction and uses thereof

 #27
20150329474
2015-11-19

Amine compound and ionic conductive agent, and electroconductive resin composition

 #28
20150024032
2015-01-22

Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia

 #29
20140309206
2014-10-16

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

 #30
20140256701
2014-09-11

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

 #31
20140249306
2014-09-04

HIV replication inhibitor

 #32
20140228443
2014-08-14

Compounds for treating ophthalmic diseases and disorders

 #33
20140031331
2014-01-30

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

 #34
20130184279
2013-07-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

 #35
20130184238
2013-07-18

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

 #36
20120295881
2012-11-22

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

 #37
20120214785
2012-08-23

Compounds, pharmaceutical compositions and uses thereof

 #38
20120077976
2012-03-29

Camphor-derived compounds, method for manufacturing the same, and application thereof

 #39
20120077796
2012-03-29

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

 #40
20120040948
2012-02-16

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

 #41
20120040947
2012-02-16

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

 #42
20120022076
2012-01-26

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

 #43
20110269955
2011-11-03

Method for preparing 2-morpholinoisobornane-10-thiol and intermediates formed therein

 #44
20100273739
2010-10-28

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

 #45
20100113539
2010-05-06

Compounds for treating ophthalmic diseases and disorders

 #46
20100041717
2010-02-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

 #47
20090082457
2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

 #48
20080058340
2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

 #49
20080045483
2008-02-21

Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes

 #50
20070155743
2007-07-05

Amino alcohol derivatives and their activity as renin inhibitors

 #51
20060270710
2006-11-30

Methods for inhibition of angiogenesis

 #52
20060058315
2006-03-16

2-Oxo-ethanesulfonamide derivates

 #53
20050085517
2005-04-21

Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative

 #54
20050070485
2005-03-31

Phenylalanine derivatives